Kilitch Drugs (India) Price Prediction
| KILITCH Stock | 336.20 15.25 4.75% |
Momentum 47
Impartial
Oversold | Overbought |
Quarterly Earnings Growth 1.005 | Wall Street Target Price 466 | Quarterly Revenue Growth 0.767 |
Using Kilitch Drugs hype-based prediction, you can estimate the value of Kilitch Drugs Limited from the perspective of Kilitch Drugs response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Kilitch Drugs to buy its stock at a price that has no basis in reality. In that case, they are not buying Kilitch because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Kilitch Drugs after-hype prediction price | INR 334.96 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Kilitch |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Kilitch Drugs' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Kilitch Drugs After-Hype Price Prediction Density Analysis
As far as predicting the price of Kilitch Drugs at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Kilitch Drugs or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Kilitch Drugs, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Kilitch Drugs Estimiated After-Hype Price Volatility
In the context of predicting Kilitch Drugs' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Kilitch Drugs' historical news coverage. Kilitch Drugs' after-hype downside and upside margins for the prediction period are 332.74 and 337.18, respectively. We have considered Kilitch Drugs' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Kilitch Drugs is very steady at this time. Analysis and calculation of next after-hype price of Kilitch Drugs Limited is based on 3 months time horizon.
Kilitch Drugs Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Kilitch Drugs is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Kilitch Drugs backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Kilitch Drugs, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.12 | 2.22 | 1.24 | 2.28 | 3 Events / Month | 1 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
336.20 | 334.96 | 0.37 |
|
Kilitch Drugs Hype Timeline
Kilitch Drugs Limited is now traded for 336.20on National Stock Exchange of India of India. The entity has historical hype elasticity of -1.24, and average elasticity to hype of competition of -2.28. Kilitch is anticipated to decline in value after the next headline, with the price expected to drop to 334.96. The average volatility of media hype impact on the company price is about 21.55%. The price decline on the next news is expected to be -0.37%, whereas the daily expected return is now at 0.12%. The volatility of related hype on Kilitch Drugs is about 11.69%, with the expected price after the next announcement by competition of 333.92. About 75.0% of the company outstanding shares are owned by corporate insiders. The book value of Kilitch Drugs was now reported as 117.76. The company recorded earning per share (EPS) of 12.13. Kilitch Drugs Limited last dividend was issued on the 20th of September 2019. Assuming the 90 days trading horizon the next anticipated press release will be in about 3 days. Check out Kilitch Drugs Basic Forecasting Models to cross-verify your projections.Kilitch Drugs Related Hype Analysis
Having access to credible news sources related to Kilitch Drugs' direct competition is more important than ever and may enhance your ability to predict Kilitch Drugs' future price movements. Getting to know how Kilitch Drugs' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Kilitch Drugs may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| TCI | Transport of | (22.80) | 7 per month | 0.00 | (0.15) | 3.69 | (3.28) | 9.07 | |
| CAMS | Computer Age Management | (131.57) | 7 per month | 0.00 | (0.18) | 3.41 | (5.33) | 13.83 | |
| PRIVISCL | Privi Speciality Chemicals | 4.70 | 4 per month | 0.00 | (0.1) | 2.94 | (4.39) | 11.85 | |
| SPORTKING | Sportking India Limited | (2.79) | 1 per month | 0.00 | (0.14) | 6.50 | (5.08) | 19.30 | |
| BHAGCHEM | Bhagiradha Chemicals Industries | 6.75 | 1 per month | 0.00 | (0.07) | 3.40 | (3.02) | 10.50 | |
| VISHNU | Vishnu Chemicals Limited | 14.35 | 3 per month | 2.47 | 0.09 | 4.50 | (3.81) | 13.07 | |
| 21STCENMGM | 21st Century Management | (1.63) | 3 per month | 0.00 | (0.35) | 1.99 | (2.01) | 4.29 |
Kilitch Drugs Additional Predictive Modules
Most predictive techniques to examine Kilitch price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Kilitch using various technical indicators. When you analyze Kilitch charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Kilitch Drugs Predictive Indicators
The successful prediction of Kilitch Drugs stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Kilitch Drugs Limited, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Kilitch Drugs based on analysis of Kilitch Drugs hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Kilitch Drugs's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Kilitch Drugs's related companies.
Story Coverage note for Kilitch Drugs
The number of cover stories for Kilitch Drugs depends on current market conditions and Kilitch Drugs' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Kilitch Drugs is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Kilitch Drugs' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Kilitch Drugs Short Properties
Kilitch Drugs' future price predictability will typically decrease when Kilitch Drugs' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Kilitch Drugs Limited often depends not only on the future outlook of the potential Kilitch Drugs' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Kilitch Drugs' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 15.9 M | |
| Cash And Short Term Investments | 690.2 M |
Complementary Tools for Kilitch Stock analysis
When running Kilitch Drugs' price analysis, check to measure Kilitch Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kilitch Drugs is operating at the current time. Most of Kilitch Drugs' value examination focuses on studying past and present price action to predict the probability of Kilitch Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kilitch Drugs' price. Additionally, you may evaluate how the addition of Kilitch Drugs to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |